Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.61 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.61 |
| ▸ | ACHE | P22303 | 7/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3148156 | 0.90 | CYP4F2 (0.54) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| SCHEMBL491452 | 0.90 | CYP4F2 (0.54) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| SCHEMBL1356716 | 0.90 | CYP4F2 (0.54) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| SCHEMBL31150688 | 0.89 | CYP4F2 (0.67) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| SCHEMBL28778154 | 0.89 | CYP4F2 (0.55) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| Ethylene SCHEMBL7768835 | 0.87 | CYP4F2 (0.53) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| SCHEMBL29218924 | 0.85 | CYP4F2 (0.51) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| SCHEMBL5172437 | 0.85 | CYP4F2 (0.51) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| SCHEMBL29149655 | 0.85 | CYP4F2 (0.50) | CYP4F2CYP4A11ACHETSHRALDH1A1 | |
| SCHEMBL1556076 | 0.84 | CYP4F2 (0.52) | CYP4F2CYP4A11ACHETSHRMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250120887-A1 | SKIN MOISTURIZING EXTERNAL COMPOSITIONS | JIN HONGJONG (KR) | 2025-04-17 | — | — | US | claimed |
| EP-4482459-A1 | SKIN MOISTURIZING EXTERNAL COMPOSITIONS | Jin, Hongjong (KR) | 2025-01-01 | — | — | EP | claimed |
| WO-2024237393-A1 | SKIN MOISTURIZING EXTERNAL COMPOSITIONS | JIN HONGJONG (KR) | 2024-11-21 | — | — | WO | claimed |
| WO-2020145495-A1 | COSMETIC COMPOSITION COMPRISING COSMETIC CAPSULES INTO WHICH WATER-SOLUBLE EXTRACT IS ABSORBED | 한국콜마주식회사 | 2020-07-16 | — | — | WO | claimed |
| US-9296978-B2 | Perfuming compositions and uses thereof | FIRMENICH SA (CH) | 2016-03-29 | — | — | US | claimed |
| CN-122055128-A | Dispersion and cosmetic containing the same | 信越化学工业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| WO-2026088899-A1 | (METH)ACRYLIC SILICONE COPOLYMER AND COSMETIC CONTAINING SAME | 信越化学工業株式会社 | 2026-04-30 | — | — | WO | disclosed |
| US-20260090977-A1 | WATER-IN-OIL COSMETIC COMPOSITION | SHINETSU CHEMICAL CO (JP) | 2026-04-02 | — | — | US | disclosed |
| EP-4717725-A1 | ORGANOPOLYSILOXANE AND COSMETIC CONTAINING ORGANOPOLYSILOXANE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-12589062-B2 | Powdery solid cosmetic preparation | SHISEIDO COMPANY, LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| EP-4714430-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-4706633-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-11 | — | — | EP | disclosed |
| EP-1602354-B1 | Use of polyglutamic acid or its salts | MEIJI SEIKA KAISHA (JP) | 2008-11-05 | — | — | EP | disclosed |
| US-20080254126-A1 | Composition comprising nanoparticle ginkgo biloba extract with the effect of brain function activation | SHIMADA SHINJI | 2008-10-16 | — | — | US | disclosed |
| WO-2008070368-A2 | METHODS AND COMPOSITIONS FOR SKIN CARE | LIVING PROOF, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| EP-1604647-B1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | CHISSO CORP (JP) | 2008-05-07 | — | — | EP | disclosed |
| US-20060165636-A1 | Hair treatment composition and hair cosmetic for damaged hair | MEIJI SEIKA KAISHA, LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| US-20060018867-A1 | Cosmetic composition and production thereof | ICHIMARU PHARCOS CO., LTD | 2006-01-26 | — | — | US | disclosed |
| EP-1604647-A1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | Ichimaru Pharcos Co., Ltd. (JP) | 2005-12-14 | — | — | EP | disclosed |
| EP-1602354-A1 | HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR | Meiji Seika Kaisha, Ltd. (JP) | 2005-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090977-A1 | WATER-IN-OIL COSMETIC COMPOSITION | DEGS1, SQLE, FDFT1 | CYP4F2 4802/4885CYP4A11 4755/4885ACHE 2500/4885 |
| US-12589062-B2 | Powdery solid cosmetic preparation | TMEM63A, CUTA, VCL | CYP4F2 3947/4885CYP4A11 4275/4885ACHE 2780/4885 |
| US-20060165636-A1 | Hair treatment composition and hair cosmetic for damaged hair | CUTA, COL14A1, PRKDC | CYP4F2 4873/4885CYP4A11 4851/4885ACHE 4326/4885 |
| US-20060018867-A1 | Cosmetic composition and production thereof | CUTA, PARG, TYR | CYP4F2 4358/4885CYP4A11 4420/4885ACHE 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.